✦ LIBER ✦

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

✍ Scribed by Ingram, W; Lea, N C; Cervera, J; Germing, U; Fenaux, P; Cassinat, B; Kiladjian, J J; Varkonyi, J; Antunovic, P; Westwood, N B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lenalidomide in a patient wi

✍ Meritxell Nomdedeu; Margherita Maffioli; Xavier Calvo; Alejandra Martínez-Trillo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 175 KB

The Development of Gastric Cancer in a P

✍ Ozlem Ayvaz; Irfan Yavasoglu; Gurhan Kadikoylu; Nezih Meydan; Sabri Barutca; Zah 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 92 KB

The JAK2 V617F mutation involves B- and

✍ Thomas Stauffer Larsen; Jacob Haaber Christensen; Hans Carl Hasselbalch; Niels P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

JAK2 mutation and disease phenotype: a d

✍ Cleyrat, C; Jelinek, J; Girodon, F; Boissinot, M; Ponge, T; Harousseau, J-L; Iss 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 296 KB

JAK2 V617F/C618R mutation in a patient w

✍ Jong-Ha Yoo; Tae Sung Park; Ho-Young Maeng; Young-Kyu Sun; Young-Ah Kim; Jeong-H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Prevalence of the JAK2V617F mutation in

✍ Xingshun Qi; Cheng Zhang; Guohong Han; Wei Zhang; Chuangye He; Zhanxin Yin; Zhiw 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB